Correlation Engine 2.0
Clear Search sequence regions

  • cohort (1)
  • conduct (1)
  • failure treatments (1)
  • humans (1)
  • ill (1)
  • imipenem (8)
  • infant (1)
  • infant newborn (1)
  • neonates (6)
  • plasma (1)
  • serum (1)
  • weight (3)
  • Sizes of these terms reflect their relevance to your search.

    Imipenem is a broad-spectrum antibacterial agent used in critically ill neonates after failure of first-line treatments. Few studies have described imipenem disposition in this population. The objectives of our study were: (i) to characterize imipenem population pharmacokinetics (PK) in a cohort of neonates; and (ii) to conduct model-based simulations to evaluate the performance of six different dosing regimens aiming at optimizing PK target attainment. A total of 173 plasma samples from 82 neonates were collected over 15 years at the Lausanne University Hospital, Switzerland. The majority of study subjects were preterm neonates with a median gestational age (GA) of 27 weeks (range: 24-41), a postnatal age (PNA) of 21 days (2-153) and a body weight (BW) of 1.16 kg (0.5-4.1). PK data were analysed using non-linear mixed-effect modelling (NONMEM). A one-compartment model best characterized imipenem disposition. Population PK parameters estimates of CL and volume of distribution were 0.21 L/h and 0.73 L, with an interpatient variability (CV%) of 20.1% on CL in a representative neonate (GA 27 weeks, PNA 21 days, BW 1.16 kg, serum creatinine, SCr 46.6 μmol/L). GA and PNA exhibited the greatest impact on PK parameters, followed by SCr. These covariates explained 36% and 15% of interindividual variability in CL, respectively.Simulated regimens using a dose of 20-25 mg/kg every 6-12 h according to postnatal age led to the highest PTA (T>MIC over 100% of time). Dosing adjustment according to BW, GA and PNA optimizes imipenem exposure in neonates. © The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email:


    Kim Dao, Aline Fuchs, Pascal André, Eric Giannoni, Laurent A Decosterd, Oscar Marchetti, Sandra A Asner, Marc Pfister, Nicolas Widmer, Thierry Buclin, Chantal Csajka, Monia Guidi. Dosing strategies of imipenem in neonates based on pharmacometric modelling and simulation. The Journal of antimicrobial chemotherapy. 2022 Feb 02;77(2):457-465

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 34791295

    View Full Text